EGFR and non-small cell lung carcinoma: Given that facilitating EGFR degradation is a potential strategy to overcome EGFR-TKI resistance (30, 34, 35, 36), we subsequently investigated the effect of nebivolol combined with curcumin on osimertinib resistance of NSCLC.